Strata Skin Sciences

Strata Skin Sciences is a publicly traded medical technology company based in Horsham, Pennsylvania. Founded in 1989, the company specializes in the design and development of non-invasive medical devices for dermatologic conditions. Their primary focus is on providing advanced tools for dermatologists to diagnose and treat skin diseases, particularly melanoma, psoriasis, and vitiligo. The flagship product, the XTRAC® Excimer Laser, delivers a targeted beam of UVB light for treating conditions like psoriasis and vitiligo. This treatment is quick and virtually painless, offering long-lasting results with fewer side effects compared to other therapies. Additionally, Strata offers the VTRAC® Excimer Lamp System, which combines the efficacy of excimer lasers with a simpler design. The company also developed MelaFind, a non-invasive diagnostic tool that aids dermatologists during melanoma examinations and has received CE Mark approval for sale in the European Union. Strata Skin Sciences markets its products primarily to dermatologists and healthcare providers, enhancing diagnostic accuracy and treatment outcomes for patients with challenging skin diseases. The company continues to expand its capabilities and market presence through strategic partnerships and acquisitions.

• Employees 110
• Founded 2016
• Annual Revenue $33620000
• Total Funding $31028736